From: Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus
Study population
ATxA IgG+
P valuea
Healthy controls
53/908 (5.8%)
Patients with an AID
Rheumatoid arthritis
12/151 (8.0%)
0.319
Sjögren’s syndrome
33/219 (15.1%)
 < 0.0001*
Systemic lupus erythematosus
144/863 (16.7%)